{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:47:49Z","timestamp":1786704469848,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.suronc.2018.02.003","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T02:19:04Z","timestamp":1519179544000},"page":"158-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer"],"prefix":"10.1016","volume":"27","author":[{"given":"Lobna","family":"Ouldamer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Chas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavie","family":"Arbion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Cirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Ballester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiane","family":"Bendifallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.suronc.2018.02.003_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2018.02.003_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","article-title":"Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis","volume":"97","author":"Mauri","year":"2005","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.suronc.2018.02.003_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.5894","article-title":"Neoadjuvant chemotherapy for operable breast cancer","volume":"94","author":"Mieog","year":"2007","journal-title":"Br. J. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2018.02.003_bib4","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1996.14.5.1558","article-title":"Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group","volume":"14","author":"Arriagada","year":"1996","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.suronc.2018.02.003_bib5","first-page":"19","article-title":"Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group","volume":"11","author":"Blichert-Toft","year":"1992","journal-title":"J.\u00a0Natl. Cancer Inst. Monogr."},{"issue":"16","key":"10.1016\/j.suronc.2018.02.003_bib6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.suronc.2018.02.003_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/cncr.11580","article-title":"Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial","volume":"98","author":"Poggi","year":"2003","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.suronc.2018.02.003_bib8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/92.14.1143","article-title":"Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: european Organization for Research and Treatment of Cancer 10801 trial","volume":"92","author":"van Dongen","year":"2000","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"16","key":"10.1016\/j.suronc.2018.02.003_bib9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"2","key":"10.1016\/j.suronc.2018.02.003_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/SLA.0b013e3182805c4a","article-title":"Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy","volume":"257","author":"Mittendorf","year":"2013","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2018.02.003_bib11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9610(98)00253-0","article-title":"Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer","volume":"176","author":"Kuerer","year":"1998","journal-title":"Am. J. Surg."},{"issue":"9938","key":"10.1016\/j.suronc.2018.02.003_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet Lond Engl"},{"issue":"12","key":"10.1016\/j.suronc.2018.02.003_bib13","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1245\/s10434-016-5339-4","article-title":"Different prognostic implications of residual disease after neoadjuvant treatment: impact of Ki 67 and site of response","volume":"23","author":"Diaz-Botero","year":"2016","journal-title":"Ann. Surg Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2018.02.003_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000658-199907000-00011","article-title":"Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy","volume":"230","author":"Kuerer","year":"1999","journal-title":"Ann. Surg."},{"issue":"16","key":"10.1016\/j.suronc.2018.02.003_bib15","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1200\/JCO.2005.07.032","article-title":"Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer","volume":"23","author":"Buzdar","year":"2005","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.suronc.2018.02.003_bib16","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.suronc.2018.02.003_bib17","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Alvarado","year":"2012","journal-title":"Ann. Surg Oncol."},{"issue":"9","key":"10.1016\/j.suronc.2018.02.003_bib18","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1245\/s10434-013-2992-8","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis","volume":"20","author":"Park","year":"2013","journal-title":"Ann. Surg Oncol."},{"issue":"9816","key":"10.1016\/j.suronc.2018.02.003_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(11)61847-3","article-title":"Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial","volume":"379","author":"Baselga","year":"2012","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"10.1016\/j.suronc.2018.02.003_bib20","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.3747\/co.20.1294","article-title":"Axillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancer","volume":"20","author":"Zhang","year":"2013","journal-title":"Curr. Oncol."},{"issue":"10","key":"10.1016\/j.suronc.2018.02.003_bib21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"6797","key":"10.1016\/j.suronc.2018.02.003_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.suronc.2018.02.003_bib23","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.suronc.2018.02.003_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.suronc.2018.02.003_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","article-title":"Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples","volume":"16","author":"Schisterman","year":"2005","journal-title":"Epidemiol Camb Mass"},{"issue":"4","key":"10.1016\/j.suronc.2018.02.003_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaoncol.2015.4935","article-title":"Ten-year outcomes of patients with breast cancer with cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy","volume":"2","author":"Mougalian","year":"2016","journal-title":"JAMA Oncol"},{"issue":"14","key":"10.1016\/j.suronc.2018.02.003_bib27","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.suronc.2018.02.003_bib28","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/bcr3198","article-title":"Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy","volume":"14","author":"Caudle","year":"2012","journal-title":"Breast Cancer Res."},{"issue":"5","key":"10.1016\/j.suronc.2018.02.003_bib29","first-page":"315","article-title":"A\u00a0model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer","volume":"14","author":"Schipper","year":"2014","journal-title":"Clin. Breast Canc."},{"issue":"3","key":"10.1016\/j.suronc.2018.02.003_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"43","key":"10.1016\/j.suronc.2018.02.003_bib31","doi-asserted-by":"crossref","first-page":"e1720","DOI":"10.1097\/MD.0000000000001720","article-title":"Prognostic nomogram for prediction of axillary pathologic complete response after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer","volume":"94","author":"Kim","year":"2015","journal-title":"Medicine (Baltim.)"},{"issue":"11","key":"10.1016\/j.suronc.2018.02.003_bib32","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1245\/s10434-016-5277-1","article-title":"Nomograms for predicting axillary response to neoadjuvant chemotherapy in clinically node-positive patients with breast cancer","volume":"23","author":"Vila","year":"2016","journal-title":"Ann. Surg Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416302614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416302614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:16:07Z","timestamp":1760757367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740416302614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0960740416302614"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2018.02.003","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2018.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}